L’Oréal unveils light-powered styling and skincare solutions at CES 2026
The launch is planned globally in 2027.
FRANCE – L’Oréal Groupe has launched two innovative beauty technology devices at CES 2026: the Light Straight + Multi-styler for hair and an ultra-thin LED Face Mask for skin, both of which were honoured with CES Innovation Awards.
These products harness infrared and LED light technologies to enhance results while protecting hair and skin integrity.
Barbara Lavernos, Deputy CEO in charge of Research, Innovation and Technology at L’Oréal Groupe, stated, “At L’Oréal, we’ve always believed that beauty is deeply connected to scientific discovery, a belief that has been central to our company since its inception over 115 years ago.”
“Today, we tirelessly combine the latest scientific and technological breakthroughs with our creativity to craft innovative beauty experiences that are more effective and tailored to individual needs.”
The Light Straight + Multi-styler uses patented near-infrared light through glass plates, limited to 320°F, avoiding the keratin damage caused by traditional straighteners that exceed 400°F, a problem for 58% of women, per a 2024 L’Oréal U.S. study.
Smart sensors with algorithms and machine learning personalize straightening, smoothing, or curling, delivering 3X faster styling and 2X smoother hair than leading premium tools, according to company tests.
According to L’Oréal, the launch is planned globally in 2027, with a French patent granted and a U.S. patent pending.
Guive Balooch, Global VP of Augmented Beauty, described the styler as advancing from repair to prevention, building on tools like Airlight Pro.
This aligns with L’Oréal’s €43.48 billion(USD 47.53 billion) in 2024 sales and its 2025 Fortune ranking as Europe’s top innovator.
Partnering with iSmart, the flexible silicone LED Face Mask prototype emits red light (630 nm) and near-infrared light (830 nm) via a microcircuit for 10-minute sessions targeting fine lines, sagging, and tone.
Its slim, comfortable design suits daily use, with expected benefits in firming and smoothing, according to L’Oréal’s testing.
A 2027 U.S. debut requires FDA 510(k) approval; further details on loreal.com.
This move comes after L’Oréal recently increased its stake in Galderma, raising its ownership from 10% to 20%, underscoring its ambitions in the fast-growing aesthetics market.
The investment was funded through L’Oréal’s available cash and credit lines, with the purchase price undisclosed.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
